A family of compounds having the general structural formula
where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
具有以下一般结构式的化合物家族:
其中W是一个反向羟
肟酸基团,而R1、R2、R3、R4、R5和R6如规范中所述,或其药学上可接受的盐、溶剂化合物、
生物水解酯、
生物水解酰胺、亲和试剂或其前药。